Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy

Clinical trial NCT02489461 · COMPLETED

Trial details

NCT number: NCT02489461
Sponsor: Viriom
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2014-08-05
Primary completion: 2016-04-05
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.